I’m not going to discuss another company on these threads any further.
I’ve commenced investing in RAC purely on cardio protection alone; on a personal note I lost my brother in law to cancer at 68y/o and I remember the chemo had to be limited due to possible heart problems occurring.
However this has probably been discussed before but what is RAC’s strategy going forward assuming successful P2 trials, sell or licensing, RAC doesn’t manufacture or have a sales network to my knowledge.
I’m not going to discuss another company on these threads any...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $311.7M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |